
Watchful waiting:
Some people with symptom-free, stable CLL may be monitored with regular examinations and blood tests rather than treated immediately.

From diagnosis and treatment planning to remission and follow-up, experience care that considers your strength, nutrition, comfort and overall wellbeing.

A diagnosis can bring many questions at once. Let us begin with the basics.
Leukemia is a group of cancers affecting blood-forming cells, usually beginning in the bone marrow. Abnormal cells can accumulate in the marrow and blood, reducing healthy red blood cells, white blood cells and platelets. This may cause fatigue, infections, easy bruising or bleeding. The four major types are acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML). Acute leukemias progress quickly and require treatment. Some chronic leukemias develop slowly and may be monitored. Diagnosis involves blood tests and, depending on the type, bone marrow examination. Flow cytometry, chromosome analysis and molecular testing identify the subtype and guide treatment.
Your haematologist may have discussed chemotherapy, targeted medicines, immunotherapy, stem cell transplantation or careful monitoring. Treatment depends on the leukemia type, genetic findings, disease status, age, overall health and response to previous treatment.
Radiation therapy has a limited role but may be used in selected situations involving the brain, spinal cord or preparation for transplantation. Supportive medical care, including transfusions, antibiotics, antifungal medicines, nausea treatment and nutritional support, is also a central part of leukemia care.

Cancer Healer Therapy (CAM) is supportive integrative care used alongside treatment prescribed by your haematologist or oncologist, not instead of it.
The supportive plan may consider appetite, fatigue, sleep, emotional wellbeing and the practical demands of prolonged or intensive treatment.
Herbal medicines and supplements can interact with chemotherapy, targeted medicines, immunotherapy, antifungal medicines and other treatments. They may also influence liver function, bleeding risk or blood counts.
Support may begin before chemotherapy, targeted therapy, immunotherapy or transplantation, with attention to blood counts, symptoms, nutrition, medicines and overall wellbeing.
Supportive care may focus on fatigue, reduced appetite, nausea, mouth discomfort, taste changes, difficulty maintaining weight, sleep problems and emotional stress.
Acute leukemia may require treatment decisions quickly. Supportive care should never delay hospital admission, chemotherapy, transfusions, infection treatment or other care recommended by your haematologist.
Cancer Healer Therapy does not replace chemotherapy, targeted therapy, immunotherapy, CAR T-cell therapy, stem cell transplantation, transfusions, antibiotics or medically supervised observation.

Most leukemias do not use the same Stage I to Stage IV system as solid tumours.
Acute leukemias may be described as:
CML is commonly divided into chronic, accelerated and blastic phases.
CLL may be staged using systems such as Rai or Binet, although stage is only one factor in deciding when treatment is needed.
Cancer Healer Therapy is intended only as supportive care and does not treat leukemia cells or replace haematology treatment.

Possible symptoms include:
These symptoms can also occur with infections and other blood disorders. Blood tests and medical assessment are needed to determine the cause.


Here’s exactly what happens from your first conversation with us to ongoing support during treatment.
We discuss your leukemia diagnosis, blood reports, bone marrow findings, symptoms and treatment plan.
The team reviews leukemia type, genetic findings, disease status, blood counts, treatment plan, symptoms and current medicines.
Supportive care is developed around the treatment or monitoring plan recommended by your haematology team.
Herbal medicines, supplements and special diets should be disclosed to your treating haematologist.
The plan may be reviewed as blood counts, symptoms and treatment needs change.
One point of contact supports appointments and follow-up communication.

Meet Dr. Tarang Krishna, MD - Cancer Healer Center
Dr. Tarang Krishna has spent over two decades developing and refining Cancer Healer Therapy, working with a multidisciplinary team across 30+ centres in India.
His work has been recognised for innovative cancer care and brings a coordinated, supportive approach to every patient journey.

Every cancer journey is personal. Read experiences shared by patients and families about the consultations, communication, follow-up and support they received at Cancer Healer Center.
4.9 Stars | 5479 Reviews
Yes. Leukemia is a group of cancers affecting blood-forming cells, usually beginning in the bone marrow.
No. Leukemia cannot spread from one person to another through normal contact or everyday activities.
No. Acute leukemias usually require prompt treatment, while some chronic leukemias such as symptom-free CLL may initially be monitored.
Leukemia usually affects blood and bone marrow rather than forming a single solid tumour. Different leukemia types are therefore classified using disease status, phases, blood counts and genetic findings.
Some leukemias can be cured, while others may be controlled for many years. The outlook depends on leukemia type, genetic findings, response to treatment and overall health.
No. Transplantation is generally considered for selected high-risk, recurrent or treatment-resistant leukemias.
No. Cancer Healer Therapy is supportive integrative care used alongside haematology treatment. It should not replace or delay chemotherapy, targeted therapy, immunotherapy, CAR T-cell therapy, transplantation or transfusions.
Leukemia and its treatment can reduce healthy infection-fighting white blood cells. Fever during periods of low white blood cells may therefore require immediate medical attention.
Risk factors vary by type and may include increasing age, previous chemotherapy or radiation, high-level ionising radiation exposure, benzene exposure, smoking for some AML cases and certain inherited conditions.
Only after discussing every product with your haematologist or oncology pharmacist. Herbs and supplements may interact with chemotherapy, targeted medicines, antifungal treatment and medicines used after transplantation.